Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Communication
  • Published:

Research goals for folate and related B vitamin in Europe

Abstract

In the past decade, the understanding of folate bioavailability, metabolism and related health issues has increased, but several problems remain, including the difficulty of delivering the available knowledge to the populations at risk. Owing to the low compliance of taking folic acid supplements, for example, among women of child-bearing age who could lower the risk of having a baby with a neural tube defect, food-based strategies aimed at increasing the intake of folate and other B-group vitamins should be a priority for future research. These should include the development of a combined strategy of supplemental folate (possibly with vitamin B12), biofortification using engineered plant-derived foods and micro-organisms and food fortification for increasing folate intakes in the general population. Currently, the most effective population-based strategy to reduce NTDs remains folic acid fortification. However, the possible adverse effect of high intakes of folic acid on neurologic functioning among elderly persons with vitamin B12 deficiency needs urgent investigation. The results of ongoing randomized controlled studies aimed at reducing the prevalence of hyperhomocysteinemia and related morbidity must be available before food-based total population approaches for treatment of hyperhomocysteinemia can be recommended. Further research is required on quantitative assessment of folate intake and bioavailability, along with a more thorough understanding of physiological, biochemical and genetic processes involved in folate absorption and metabolism.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  • Afman LA, Trijbels FJM, Blom HJ (2003). The H475Y polymorphism in the glutamate carboxypeptidase II gene increases plasma folate without affecting the risk for neural tube defects in humans. J Nutr 133, 75–77.

    Article  CAS  Google Scholar 

  • Baker F, Picton D, Blackwood S, Hunt J, Erskine M, Dyas M et al. (2002). Blinded comparison of folic acid and placebo in patients with ischemic heart disease: an outcome trial. Circulation 106, 3642 (abstract).

    Google Scholar 

  • Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H et al. (1999). Prevention of neural tube defects with folic acid in China. China–U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 341, 1485–1490.

    Article  CAS  Google Scholar 

  • Botto LD, Lisi A, Robert-Gnansia E, Erickson JD, Vollset SE, Mastroiacovo P et al. (2005). International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working? BMJ, doi: 19.1136/bmj.38336.664352.82 (published 18 February 2005).

  • Brouwer IA, van Dusseldorp M, West CE, Steegers-Theunissen RPM (2001). Bioavailability and bioefficacy of folate and folic acid in man. Nutr Res Rev 14, 267–293.

    Article  CAS  Google Scholar 

  • Buttriss J (2005). Strategies designed to increase awareness about folates and health, and to increase folate intake: a review. Trends Food Sci Technol 16, 246–252.

    Article  CAS  Google Scholar 

  • Carter JY, Loolpapit MP, Lema OE, Tome JL, Nagelkirke NJ, Watkins WM (2005). Reduction of the efficacy of antifolate antimalarial theraphy by folic acid supplementation. Am J Trop Med Hyg 73, 166–170.

    Article  CAS  Google Scholar 

  • Choi S-W, Mason JB (2000). Folate and carcinogenesis: an integrated scheme. J Nutr 130, 129–132.

    Article  CAS  Google Scholar 

  • Choumenkovitch SF, Selhub J, Wilson PWF, Rader JI, Rosenberg IH, Jacques PF (2002). Folic acid intake from fortification in United States exceeds predictions. J Nutr 132, 2792–2798.

    Article  CAS  Google Scholar 

  • Cuskelly GJ, McNulty H, Scott JM (1996). Effect of increasing dietary folate on red-cell folate: implications for prevention of neural tube defects. Lancet 347, 657–659.

    Article  CAS  Google Scholar 

  • Czeizel AE, Dudas I (1992). Prevention of the first occurrence of neural tube defects by periconceptual vitamin supplementation. New Engl J Med 327, 32–35.

    Article  Google Scholar 

  • Daly LE, Kirke PN, Molloy A, Weir DG, Scott JM (1995). Folate levels and neural tube defects. Implications for prevention. JAMA 274, 1698–1702.

    Article  CAS  Google Scholar 

  • Daly S, Mills JL, Molloy AM, Conley M, Lee YJ, Kirke PN et al. (1997). Minimum effective dose of folic acid for food fortification to prevent neural-tube defects. Lancet 350, 1666–1669.

    Article  CAS  Google Scholar 

  • de la Vega A, Salicrup E, Verdiales M (2002). A nationwide program for the use of preconceptional folic acid to prevent the development of open neural tube defects. Who is really using folic acid? Puerto Rico Health Sci J 21, 7–9.

    Google Scholar 

  • de Meer K, Pietrzik K, Finglas PM (2004). Meta-analysis of results from human intervention studies investigating folate absorption and effects on homocysteine. In Brzozowska A, Finglas PM, Wright D, Araucz M (eds). First International Conference on Folates – Analysis, Bioavailability and Health. Warsaw Agricultural University Press: Warsaw. pp. 121–122.

    Google Scholar 

  • de Meer K, Smulders YM, Dainty JR, Smith DEC, Kok RM, Stehouwer CDA et al. (2005). Effect of [6S]5-methyltetrahydrofolate or folic acid supplementation on absorption and initial elimination of folate in young and elderly adults. Euro J Clin Nutr (in press).

  • Devlin AM, Ling E-H, Peerson JM, Fernando S, Clarke R, Smith AD et al. (2000). Glutamate carboxypeptidase II: a polymorphism associated with lower levels of serum folate and hyperhomocysteinemia. Hum Mol Genet 9, 2837–2844.

    Article  CAS  Google Scholar 

  • Finglas PM, Wright AJA, Wolfe CA, Hart DJ, Wright DM, Dainty JR (2003). Is there more to folates than neural-tube defects? Proc Nutr Soc 62, 591–598.

    Article  CAS  Google Scholar 

  • French AE, Grant R, Weitzman S, Ray JG, Vermeulen MJ, Sung L et al. (2003). Folic acid food fortification is associated with a decline in neuroblastoma. Clin Pharmacol Ther 74, 288–294.

    Article  CAS  Google Scholar 

  • Giovannucci E (2002). Epidemiologic studies of folate and colorectal neoplasia: a review. J Nutr 132, 2350S–2355S.

    Article  CAS  Google Scholar 

  • Gregory JF (1997). Bioavailability of folate. Eur J Clin Nutr 51 (Suppl 1), S54–S59.

    PubMed  Google Scholar 

  • Gregory JF, Quinlivan EP (2002). In vivo kinetics of folates. Annu Rev Nutr 22, 199–220.

    Article  CAS  Google Scholar 

  • Gregory JF, Quinlivan EP, Davis SR (2005). Integrating the issues of folate bioavailability, intake and metabolism in the era of fortification. Trends Food Sci Technol 16, 229–240.

    Article  CAS  Google Scholar 

  • Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LY (2001). Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 285, 2981–2986.

    Article  CAS  Google Scholar 

  • Institute of Medicine (2000). Dietary Reference Intakes for Thiamine, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, pantothenic acid, Biotin and Choline. National Academy Press: Washington, DC.

  • Jackson MJ (1997). The assessment of bioavailability of micronutrients: introduction. Eur J Clin Nutr 51 (Suppl), S1–S2.

    PubMed  Google Scholar 

  • Jacques PF, Selhub J, Bostom AG, Wilson PW, Rosenburg IH (1999). The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 340, 1449–1454.

    Article  CAS  Google Scholar 

  • Johanning GL, Heimburger DC, Piyathilake CJ (2002). DNA methylation and diet in cancer. J Nutr 132, 3814S–3818S.

    Article  Google Scholar 

  • Kim Y-I (2004). Will mandatory folic acid fortification prevent or promote cancer? Am J Clin Nutr 80, 1123–1128.

    Article  CAS  Google Scholar 

  • Koebnick C, Heins UA, Hoffmann I, Dagnelie PC, Leitzmann C (2001). Folate status during pregnancy in women is improved by long-term high vegetable intake compared with the average western diet. J Nutr 131, 733–739.

    Article  CAS  Google Scholar 

  • Lamers Y, Prinz-Langenohl R, Moser R, Pietrzik K (2004). Supplementation with [6S]-5-methyltetrahydrofolate or folic acid equally reduces plasma total homocysteine concentrations in healthy women. Am J Clin Nutr 79, 473–478.

    Article  CAS  Google Scholar 

  • Lin Y, Dueker SR, Follett JR, Fadel JG, Arjomand A, Schneider PD et al. (2004). Quantitation of in vivo human folate metabolism. Am J Clin Nutr 80, 680–691.

    Article  CAS  Google Scholar 

  • Lopez-Camelo JS, Orioli IM, Dutra M, Nazer-Herrera J, Rivera N, Ojeda ME et al. (2005). Reduction of birth prevalence rates of neural tube defects after folic acid fortification in Chile. Am J Med Genet Part A 135A, 120–125.

    Article  Google Scholar 

  • March of Dimes Birth Defects Foundation (2001). Folic Acid and the Prevention of Birth Defects. A National Survey of Pre-pregnancy Awareness and Behaviour Among Women of Childbearing Age 1995–2001. March of Dimes Birth Defects Foundation: White Plains, NY.

  • McLean RR, Jacques PF, Selhub J, Tucker KL, Samelson EJ, Broe KE et al. (2004). Homocysteine as a predictive factor for hip fracture in older patients. N Engl J Med 350, 2042–2049.

    Article  CAS  Google Scholar 

  • Melse-Boonstra A, Lievers KJA, Blom HJ, Verhoef P (2004a). Bioavailability of polyglutamyl folic acid relative to that of monoglutamyl folic acid in subjects with different genotypes of the glutamate carboxypeptidase II gene. Am J Clin Nutr 80, 700–704.

    Article  CAS  Google Scholar 

  • Melse-Boonstra A, Verhoef P, West C (2004b). Quantifying folate bioavailability: a critical appraisal of methods. Curr Opin Clin Nutr Metab Care 7, 539–545.

    Article  Google Scholar 

  • Miller M, Bower C, payne J, Serna P (2000). Folate-related knowledge and practices of Western Australian women before and during pregnancy. Teratology 62, 367.

    Google Scholar 

  • Mills JL, von Kohorn I, Conley MR, Zeller JA, Cox C, Williamson RE et al. (2003). Low vitamin B12 concentrations in patients without anaemia: the effect of folic acid fortification of grain. Am J Clin Nutr 77, 1474–1477.

    Article  CAS  Google Scholar 

  • Morris MC, Evans DA, Bienias JL, Tangney CC, Hebert LE, Scherr PA et al. (2005). Dietary folate and vitamin B12 intake and cognitive decline among community-dwelling older persons. Arch Neurol 62, 641–645.

    Article  Google Scholar 

  • MRC Vitamin Study Reseach Group (1991). Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338, 131–137.

  • Pentieva K, McNulty H, Reuchert R, Ward M, Strain JJ, McKillop DJ (2004). The short-term bioavalabilities of [6S]-5-methyltetrahydrofolate and folic acid are equivalent in men. J Nutr 134, 580–585.

    Article  CAS  Google Scholar 

  • Persad VL, van den Hof MC, Dube JM, Zimmer P (2002). Incidence of open neural tube defects in Nova Scotia after folic acid fortification. Canad Med Assoc J 167, 255–256.

    Google Scholar 

  • Pfeiffer CM, Caudill SP, Gunter EW, Osterloh J, Sampson EJ (2005). Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999–2000. Am J Clin Nutr 82, 442–450.

    Article  CAS  Google Scholar 

  • Quinlivan EP, Gregory JF (2003). Effect of food fortification on folic acid intake in the United States. Am J Clin Nutr 77, 221–225.

    Article  CAS  Google Scholar 

  • Rampersaud GC, Bailey LB, Kauwell GPA (2002). Relationship of folate to colorectal and cervical cancer: review and recommendations for practitioners. J Am Diet Assoc 102, 1273–1282.

    Article  Google Scholar 

  • Ray JG, Langman LJ, Mamdani MM, Cole DEC (2005). Absence of effect of folic acid flour fortification on anticonvulsant drug levels. Am J Med 118, 444–445.

    Article  CAS  Google Scholar 

  • Ray JG, Meier C, Vermeulen MJ, Boss S, Wyatt PR, Cole DE (2002). Association of neural tube defects and folic acid fortification in Canada. Lancet 360, 2047–2048.

    Article  Google Scholar 

  • Sanderson P, McNulty H, Mastroiacovo P, McDowell FW, Melse-Boonstra A, Finglas PM et al. (2003). Folate bioavailability: UK Food Standards Agency workshop report. Br J Nutr 90, 473–479.

    Article  CAS  Google Scholar 

  • Sauberlich HE, Kretsch MJ, Skala JH, Johnson HL, Taylor PC (1987). Folate requirement and metabolism in nonpregnant women. Am J Clin Nutr 46, 1016–1028.

    Article  CAS  Google Scholar 

  • Scott J, Rebeille F, Fletcher J (2000). Folic acid and folates: the feasibility for nutritional enhancement in plant foods. J Sci Food Agr 80, 795–824.

    Article  CAS  Google Scholar 

  • Sybesma W, Starrenburg M, Kleerebezem M, Mierau I, de Vos WM, Hugenholtz J (2003). Increased production of folate by metabolic engineering of Lactococcus lactis. Appl Environ Microbiol 69, 3069–3076.

    Article  CAS  Google Scholar 

  • Takacs P, Rodriguez L (2005). High folic acid levels and failure of single-dose methotrexate treatment in ectopic pregnancy. Int J Gynecol Obstet 89, 301–302.

    Article  CAS  Google Scholar 

  • The Arabidopsis Genome Initiative (2000). Analysis of the genome sequence of the flowering plant Arabidopsis thaliana. Nature 408, 796–815.

  • Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ et al. (2004). Lowering homoxcysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction and death. JAMA 291, 565–575.

    Article  CAS  Google Scholar 

  • Ubbink JB (2001). What is a desirable homocysteine level?. In: Carmel R, Jacobsen DW (eds.) Homocysteine in Health and Disease Chapter 40. Cambridge University Press: Cambridge.

    Google Scholar 

  • van Meurs JBJ, Dhonukshe-Rutten RAM, Pluijm SMF, van der Klift M, de Jonge R, Lindemans J et al. (2004). Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 350, 2033–2041.

    Article  CAS  Google Scholar 

  • Van Oort FV, Melse-Boonstra A, Brouwer IA, Clarke R, West CE, Katan MB et al. (2003). Folic acid reduction of plasma homocysteine concentrations in older aldults: a dose–response study. Am J Clin Nutr 77, 1318–1323.

    Article  CAS  Google Scholar 

  • Vargas-Martinez C, Ordovas JM, Wilson PW, Selhub J (2002). The glutamate carboxypeptidase gene II (C>T) polymorphism does not affect folate status in the Framingham Offspring cohort. J Nutr 132, 1176–1179.

    Article  CAS  Google Scholar 

  • Verwei M, Arkbage K, Mocking H, Havenaar R, Groten J (2004). The binding of folic acid and 5-methyltetrahydrofolate to folate-binding proteins during gastric passage differs in a dynamic in vitro gastrointestinal model. J Nutr 134, 31–37.

    Article  CAS  Google Scholar 

  • Wald NJ (2004). Folic acid and the prevention of neural tube defects. N Engl J Med 305, 101–103.

    Article  Google Scholar 

  • Wild J, Sutcliff M, Schorah CJ, Levene MI (1997). Prevention of neural-tube defects. Lancet 350, 30–31.

    Article  CAS  Google Scholar 

  • Wright AJA, Finglas PM, Dainty JR, Wolfe CA, Hart DJ, Wright DM et al. (2005). Differential kinetic behaviour and distribution for pteroylglutamic acid and reduced folates: A revised hypothesis of the primary site of PteGlu metabolism in humans. J Nutr 135, 619–623.

    Article  CAS  Google Scholar 

  • Yang TL, Hung J, Caudill MA, Urrutia TF, Alamilla A, Perry CA et al. (2005). A long-term controlled folate feeding study in young women supports the validity of the 1.7 multiplier in the dietary folate equivalency equation. J Nutr 135, 1139–1145.

    Article  CAS  Google Scholar 

  • Yu J, Hu SN, Wang J, Wong GKS, Li SG, Liu B et al. (2002). A draft sequence of the rice genome (Oryza saliva L. ssp indica). Science 296, 79–92.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The EuroFoodFolate conference and the preparation of this paper were partly supported from a grant from the Quality of Life and Management of Living Resources Programme, Key Action 1 on Food, Nutrition and Health (QLK1-CT-2002-30475).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P M Finglas.

Additional information

Guarantor: PM Finglas.

Contributors: KDM and PF prepared the original draft and edited the various contributions and remarks from the other authors; AM prepared the section on neural tube defects; PV and KP prepared the section on hyperhomocysteinemia; HP and GVM prepared the section on cancer; KDM and AM prepared the section on vitamin B12; AW, MJ, TVV, RH and JB prepared the section on bioavailability and potential strategies to increase dietary folate intakes; and DVS and MJ prepared the section on biotechnology.

This work is dedicated to Professor Clive West (deceased August 27, 2004; Division of Human Nutrition, Wageningen University, The Netherlands), who was an outstanding researcher in the field of vitamin bioavailability and status, and contributed to the Conference.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Finglas, P., de Meer, K., Molloy, A. et al. Research goals for folate and related B vitamin in Europe. Eur J Clin Nutr 60, 287–294 (2006). https://doi.org/10.1038/sj.ejcn.1602315

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ejcn.1602315

Keywords

This article is cited by

Search

Quick links